China-based ClouDr Group Limited (HKG: 9955) announced the integration of the DeepSeeker R1 model into its exclusive medical artificial intelligence (AI) product, CloudrBrain. The move aims to enhance CloudrBrain’s digital mining capabilities and improve the efficiency of chronic disease management through its hospital SaaS and pharmacy SaaS solutions.
Enhancing AI-Driven Healthcare Solutions
The integration of DeepSeeker R1 combines advanced data analysis and AI technology to upgrade ClouDr’s ClouD GPT and ClouD DTx models. This enhancement will significantly boost the functionality of the medical knowledge graph and clinical decision support system. Leveraging the company’s extensive database of over 1 billion electronic medical records, ClouDr aims to deliver more accurate and efficient healthcare solutions for chronic disease management.-Fineline Info & Tech
